Brand GLP-1 pricing · September 2026
TrumpRx GLP-1 Prices in 2026: Wegovy, Ozempic and Zepbound Cash Rates Explained
What TrumpRx.gov actually lists for GLP-1s as of September 2026: Wegovy pill $149/month, Wegovy and Ozempic pens $199/month for two fills then $349, Zepbound vial $299/month, who qualifies, how the coupon works, and where compounded treatment fits.
In one paragraph: TrumpRx.gov is a government website that lists manufacturer cash prices for brand-name drugs and issues a pharmacy coupon. For GLP-1s, as of September 4, 2026, it lists the Wegovy pill at $149/month, the Wegovy pen and the Ozempic pen at $199/month for the first two monthly fills (0.25 mg and 0.5 mg) and $349/month after that, and the Zepbound vial at $299/month. The offers are for self-pay U.S. residents with a prescription and exclude government-program beneficiaries. Prices are a snapshot; confirm at source.
The Prices, as Listed
| Product | TrumpRx cash price | Listed retail price | Terms shown |
|---|---|---|---|
| Wegovy pill (oral semaglutide) | $149/month | $1,349 | Self-pay; prescription required |
| Wegovy pen (semaglutide injection) | $199/month for the first two fills, then $349/month | $1,349 | Intro price on 0.25 mg and 0.5 mg only; new patients; 11/17/2025–12/31/2026 |
| Ozempic pen (semaglutide injection) | $199/month for the first two fills, then $349/month | $1,028 | Same intro structure and window as the Wegovy pen |
| Zepbound vial (tirzepatide injection) | $299/month | $1,087 | Single-dose vials; check dose-specific terms on the site |
Source: TrumpRx.gov product pages, read September 4, 2026. The site presents savings as the gap between the listed retail price and the cash offer.
How the Program Works
- Get a prescription from your own clinician. TrumpRx does not prescribe; you bring a valid prescription for the brand product.
- Choose the product and strength on TrumpRx.gov. For the pens, the site asks how many prior fills you have had, because the $199 price applies only to the first two monthly fills of the starting strengths.
- Accept the terms. You confirm you are a self-pay patient, a U.S. resident, and not using a government healthcare program for the purchase.
- Present the coupon at a participating pharmacy. The pharmacy applies the manufacturer's price; TrumpRx itself does not sell or ship medication.
Who Qualifies, and Who Does Not
The offers are written for cash-pay patients. The terms exclude purchases made under any state, federal or other government healthcare program, naming Medicare, Medicare Part D and Medicare Advantage, and they state that the purchase is not conditioned on future purchases billable to those programs. Commercially insured patients are told to check their co-pay first, which may be lower. The introductory pen price is limited to new patients and to the two lowest strengths, so anyone already established on a higher maintenance dose pays the ongoing $349/month figure from the start.
TrumpRx, LillyDirect and NovoCare
The prices on TrumpRx are the manufacturers' direct-to-consumer cash prices, surfaced in one place with a coupon mechanism. Eli Lilly's LillyDirect program for Zepbound and Novo Nordisk's WegovyDirect and NovoCare cash-pay channels are the underlying programs, and in some cases buying through the manufacturer directly ships the medication to you rather than routing through a retail pharmacy. If you are choosing among them, compare the dose-specific price, whether the offer is introductory, and whether shipping or pharmacy pickup suits you.
Where Compounded Treatment Fits
TrumpRx prices are for FDA-approved brand products. Compounded semaglutide and tirzepatide contain the active ingredient in the brand products but are prepared per individual prescription by state-licensed 503A pharmacies and are not themselves FDA-approved as drugs. They are a different product on a different legal pathway, explained in our 503A vs 503B guide, and the choice between a brand product and a compounded preparation belongs with a licensed clinician. For the full map of lawful ways to get a GLP-1 in 2026, brand and compounded, see our overview of legal GLP-1 access.
Frequently Asked Questions
What GLP-1 prices does TrumpRx list?
As of September 2026, TrumpRx.gov lists four GLP-1 products at manufacturer cash prices: the Wegovy pill at $149 per month, the Wegovy pen at $199 per month for the first two monthly fills of the 0.25 mg and 0.5 mg strengths and $349 per month after that, the Ozempic pen at the same $199-then-$349 structure, and the Zepbound vial at $299 per month. The introductory $199 pen offers run from November 17, 2025 through December 31, 2026 for new self-pay patients. The site shows each product's list price alongside the offer: $1,349 for Wegovy, $1,028 for Ozempic and $1,087 for Zepbound.
Who is eligible for TrumpRx GLP-1 pricing?
The offers are for self-pay patients who are residents of the United States or a U.S. territory and who hold a valid prescription. The terms exclude anyone using a state, federal or other government healthcare program for the purchase, including Medicare, Medicare Part D and Medicare Advantage, and they state that buying under the program is not conditioned on any future purchase that could be billed to a government program. If you have commercial insurance, the site suggests checking your co-pay first, since it may be lower than the cash offer.
How does TrumpRx work?
TrumpRx.gov is a government website that surfaces manufacturer direct-to-consumer cash prices. You select a product and strength, agree to the offer terms, and receive a coupon to present at a participating pharmacy along with a prescription from your own clinician. The site does not prescribe, sell or ship medication itself; the transaction happens at the pharmacy under the manufacturer's program.
Is TrumpRx the same as LillyDirect or NovoCare?
No, but they overlap. LillyDirect (Eli Lilly) and NovoCare or WegovyDirect (Novo Nordisk) are the manufacturers' own direct-to-consumer channels, and their cash prices feed the offers TrumpRx lists. TrumpRx aggregates those manufacturer prices in one place and routes you to a pharmacy with a coupon rather than shipping from the manufacturer. Our guides to LillyDirect Zepbound pricing and WegovyDirect and NovoCare cash pay cover the manufacturer channels in detail.
How does TrumpRx compare with compounded GLP-1 treatment?
They are different products. TrumpRx prices are for the FDA-approved brand medications Wegovy, Ozempic and Zepbound. Compounded semaglutide contains the active ingredient in Wegovy and Ozempic, and compounded tirzepatide the active ingredient in Zepbound; both are prepared per individual prescription by state-licensed 503A pharmacies and are not themselves FDA-approved as drugs. Brand products come in pre-filled pens or the new Wegovy pill; compounded preparations are typically multi-dose vials with separate syringes. Which path is appropriate depends on your clinician's assessment, your budget and whether you prefer an FDA-approved finished product.
Will TrumpRx prices change?
The site's own terms date the introductory pen offers to end on December 31, 2026, and manufacturer cash prices have changed several times since 2024. Treat any figure on this page as a snapshot from September 2026 and confirm the current offer on TrumpRx.gov before making a decision.
Not sure which path is right for you?
A licensed clinician can review your history and goals in a short online visit. Eligibility is determined individually; individual results vary.
Start your online visitMore on cost & affordability
LillyDirect Zepbound Pricing Guide
Eli Lilly's direct cash-pay vials, dose by dose
WegovyDirect and NovoCare Cash Pay
Novo Nordisk's direct channels explained
Cheapest Legal GLP-1 Online in 2026
Every lawful path, brand and compounded
503A vs 503B Compounding
Why compounded preparations are not FDA-approved
Medical Disclaimer: Prices and program terms are a snapshot from TrumpRx.gov on September 4, 2026 and change without notice; confirm at source before acting. This content is informational and non-partisan, is not medical or financial advice, and does not constitute an endorsement of any government program. Compounded medications are not FDA-approved. GLP-1 medicines, brand or compounded, carry risks including nausea and other gastrointestinal effects, pancreatitis, gallbladder disease, kidney injury, and a boxed warning for thyroid C-cell tumors observed in rodents; individual results vary. Consult a qualified healthcare provider before starting any medication.
Sources & References
- TrumpRx.gov product pages for Wegovy pill, Wegovy pen, Ozempic pen and Zepbound vial, including offer terms and eligibility conditions, read September 4, 2026. trumprx.gov
- FDA Prescribing Information for Wegovy (semaglutide), Ozempic (semaglutide) and Zepbound (tirzepatide).
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov